Arthritis Drugs Could Treat Persistent COVID Lung Complications
New research suggests that existing FDA-approved medications may help treat lingering lung complications caused by COVID-19 by disrupting harmful immune responses.
New research suggests that existing FDA-approved medications may help treat lingering lung complications caused by COVID-19 by disrupting harmful immune responses.
The Cleveland Clinic ReCOVer Clinic is enrolling Long COVID patients in the NIH RECOVER-VITAL clinical study.
Research reveals the lasting effects of influenza infection, or "Long Flu," are similar to the negative effects of COVID-19, including rehospitalization, multi-organ complications, and death.
The National Institutes of Health has opened enrollment for Phase 2 clinical trials to evaluate at least four potential treatments for long COVID.
Read MoreIn a new study investigating the impact of long COVID on cognitive performance, significant changes were observed in mental abilities among certain long-haulers, with the effects lasting years for some.
Read MoreFemale patients diagnosed with long COVID exhibited clinically and statistically significant improvements in multiple long COVID symptoms when treated open-label with a combination of valacyclovir and celecoxib in an exploratory, proof of concept study.
Read MoreResearchers have discovered that a widely prescribed medication for diabetes management can effectively inhibit the onset of long COVID.
Read MoreLong COVID was more common and severe in study participants infected before the 2021 Omicron variant, according to initial findings from a study of nearly 10,000 Americans.
Read MoreNew research into long COVID found clinical symptoms vary and include fatigue, brain fog, and dizziness, and last for months or years after initial infection.
Read MoreThe test can help physicians diagnose long COVID, differentiate it from diseases with similar symptoms, and provide insights into personalized treatment approaches.
Read MoreThe research suggests close monitoring after a COVID-19 infection may help adults with sleep apnea.
Read MoreHyperbaric oxygen therapy promoted restoration of the heart’s ability to contract properly in patients with long COVID, according to research presented at EACVI 2023.
Read MorePeople who perceived that they had cognitive difficulties such as memory problems during COVID were more likely to have lingering physical manifestations of the disease.
Read MoreA study of long COVID patients with persistent neurological symptoms were found to have differences in their immune cell profiles and autonomic dysfunction, according to new research.
Read MoreTwelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health and were found to have differences in their immune cell profiles and autonomic dysfunction.
Read More